Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Salzman

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Archives of Internal Medicine|March 15, 2006
Racial disparities in access after regulatory surveillance of benzodiazepinesSallie-Anne Pearson, Stephen Soumerai, Connie Mah, et al.
Clinical Therapeutics|March 25, 2004
A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disordersLinda Simoni-Wastila, Dennis Ross-Degnan, Connie Mah, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 12, 2020
The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressedRichard Balon, Vladan Starcevic, Edward Silberman, et al.
International Journal of Psychiatry in Medicine|September 25, 2004
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid populationDennis Ross-Degnan, Linda Simoni-Wastila, Jeffrey S Brown, et al.
Journal of Psychopharmacology (Oxford, England)|July 16, 2019
Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatmentLaiana A Quagliato, Fiammetta Cosci, Richard I Shader, et al.
Psychotherapy and Psychosomatics|May 23, 2018
International Task Force on BenzodiazepinesRichard Balon, Guy Chouinard, Fiammetta Cosci, et al.
Journal of Clinical Psychopharmacology|June 19, 2018
The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational ApproachAntonio E Nardi, Fiammetta Cosci, Richard Balon, et al.
The Journal of Clinical Psychiatry|May 23, 2008
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policyCarl Salzman, Dilip V Jeste, Roger E Meyer, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|March 15, 2006
Racial disparities in access after regulatory surveillance of benzodiazepinesSallie-Anne Pearson, Stephen Soumerai, Connie Mah, et al.
Clinical Therapeutics|March 25, 2004
A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disordersLinda Simoni-Wastila, Dennis Ross-Degnan, Connie Mah, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 12, 2020
The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressedRichard Balon, Vladan Starcevic, Edward Silberman, et al.
International Journal of Psychiatry in Medicine|September 25, 2004
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid populationDennis Ross-Degnan, Linda Simoni-Wastila, Jeffrey S Brown, et al.
Journal of Psychopharmacology (Oxford, England)|July 16, 2019
Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatmentLaiana A Quagliato, Fiammetta Cosci, Richard I Shader, et al.
Psychotherapy and Psychosomatics|May 23, 2018
International Task Force on BenzodiazepinesRichard Balon, Guy Chouinard, Fiammetta Cosci, et al.
Journal of Clinical Psychopharmacology|June 19, 2018
The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational ApproachAntonio E Nardi, Fiammetta Cosci, Richard Balon, et al.
The Journal of Clinical Psychiatry|May 23, 2008
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policyCarl Salzman, Dilip V Jeste, Roger E Meyer, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Pageof 7